An oral TRPV1 antagonist attenuates laser radiant‐heat‐evoked potentials and pain ratings from UVB‐inflamed and normal skin
Schaffler, Klaus, Reeh, Peter, Duan, W. Rachel, Best, Andrea E., Othman, Ahmed A., Faltynek, Connie R., Locke, Charles, Nothaft, Wolfram
Published in British journal of clinical pharmacology (01.02.2013)
Published in British journal of clinical pharmacology (01.02.2013)
Get full text
Journal Article
Integrated safety analysis of venetoclax monotherapy in chronic lymphocytic leukemia (CLL)
Davids, Matthew Steven, Gerecitano, John F., Potluri, Jalaja, Cerri, Elisa, Kim, Su Young, Steinberg, Mark, Verdugo, Maria, Busman, Todd A., Enschede, Sari H., Mobasher, Mehrdad, Best, Andrea, Desai, Monali B, Wierda, William G.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
An oral TRPV 1 antagonist attenuates laser radiant‐heat‐evoked potentials and pain ratings from UV B ‐inflamed and normal skin
Schaffler, Klaus, Reeh, Peter, Duan, W. Rachel, Best, Andrea E., Othman, Ahmed A., Faltynek, Connie R., Locke, Charles, Nothaft, Wolfram
Published in British journal of clinical pharmacology (01.02.2013)
Published in British journal of clinical pharmacology (01.02.2013)
Get full text
Journal Article
An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin
Schaffler, Klaus, Reeh, Peter, Duan, W Rachel, Best, Andrea E, Othman, Ahmed A, Faltynek, Connie R, Locke, Charles, Nothaft, Wolfram
Published in British journal of clinical pharmacology (01.02.2013)
Published in British journal of clinical pharmacology (01.02.2013)
Get full text
Journal Article